SCHEMBL3978820

SCHEMBL3978820

CC(C)(C)OC(=O)C1CNC(C(=O)O)CN1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.39
CYP1A2 P05177 2/20 0.39
ALOX15 P16050 2/20 0.39
CYP2C19 P33261 2/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
EGLN1 Q9GZT9 1/20 0.34
LMNA P02545 2/20 0.33
BLM P54132 2/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
THRB P10828 1/20 0.33
PMP22 Q01453 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPK1 P28482 1/20 0.33
BTK Q06187 1/20 0.33
ARG1 P05089 1/20 0.32
HRH3 Q9Y5N1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16008684 0.83 MAPK1 (0.36) MAPK1
SCHEMBL4103214 0.81 MAPK1 (0.32) MAPK1
SCHEMBL17715146 0.80 CYP1A2 (0.58) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL28877604 0.80 CYP2D6 (0.58) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL1460088 0.80 CYP1A2 (0.58) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL9986032 0.79 CYP1A2 (0.43) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL14720132 0.79 NR1H2 (0.33) MAPK1
SCHEMBL31000696 0.79 CYP1A2 (0.43) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL9356138 0.78 CYP2D6 (0.56) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3
SCHEMBL9356321 0.78 CYP2D6 (0.56) CYP2D6CYP1A2ALOX15CYP2C19SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054417-A2 FUSED THIOPHENE DERIVATIVES AS MEK INHIBITORS UCB Pharma S.A. (BE) 2009-05-06 EP disclosed
WO-2008020206-A2 FUSED THIOPHENE DERIVATIVES AS MEK INHIBITORS UCB PHARMA S.A. (BE) 2008-02-21 WO disclosed